Alain Huriez, Chairman
Alain is Chairman and Managing Partner of Advent France Biotechnology. Alain brings over 30 years of experience in the Life Sciences sector. Alain’s medical and biotechnological background, experience as an entrepreneur and a leading executive, expertise in clinical development and financing as well as his networks are keys to identifying early-stage biotechnology projects and to mentoring managers into building successful businesses.
Raj is a general partner at Advent Life Science, he brings over 20 years of experience in biomedical research and as an entrepreneur and investor.
After gaining an MA and DPhil from Oxford University, he pursued a successful academic career in molecular medicine before co-founding Oxford GlycoSciences (IPO on LSE and NASDAQ). Following its sale to UCB-Celltech, he became Chairman of Galapagos nv, a member of the Supervisory Board of the Novartis Venture Fund and a founding Director of Celldex Therapeutics.
Giuseppina Caligiuri, Scientific Founder
Giuseppina is research director (DR2-HDR) at INSERM U1148 (Cardiovascular Immunobiology at Bichat Hospital in Paris). After an initial training in Medicine and Surgery (Catholic University, Rome, IT), and a PhD in Science (Karolinska Institute, Stockholm, Université Paris VII), Giuseppina developed a research program about immunoregulation in atherothrombosis, rheumatoid arthritis and multiple sclerosis. In 2006, she obtained her Research Leading Habilitation (Faculté de Médecine, Paris V) to work on the role of CD31 in atherosclerosis physiopathology.